Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of rheumatoid arthritis: we are getting there.

× No keyword cloud information.

15 in total

1. Rheumatoid arthritis: Evidence-based rather than habit-based treatment options.

Authors: Yusuf Yazici
Journal: Nat Rev Rheumatol Date: 2012-05-29 Impact factor: 20.543

2. Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort.

Authors: Jie Zhang; Ying Shan; George Reed; Joel Kremer; Jeffrey D Greenberg; Scott Baumgartner; Jeffrey R Curtis
Journal: Arthritis Care Res (Hoboken) Date: 2011-12 Impact factor: 4.794

3. Therapy: what should we do after the failure of a first anti-TNF?

Authors: Chris Deighton
Journal: Nat Rev Rheumatol Date: 2009-11 Impact factor: 20.543

4. Rheumatoid arthritis: When should we use rituximab to treat RA?

Authors: Yusuf Yazici
Journal: Nat Rev Rheumatol Date: 2011-05-31 Impact factor: 20.543

5. [Janus kinase inhibitors].

Authors: E Ostermeier; P Roll; H-P Tony
Journal: Z Rheumatol Date: 2012-08 Impact factor: 1.372

6. Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?

Authors: Ling-Chun Huang; Yu-Han Chang; Yuan-Han Yang
Journal: Neurotherapeutics Date: 2019-07 Impact factor: 7.620

7. CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response.

Authors: H Wang; J Zhao; H Zhang; Y Huang; S Wang; Q Tu; N Yang
Journal: Clin Exp Immunol Date: 2014-05 Impact factor: 4.330

8. A systematic review of the factors associated with the initiation of biologicals in patients with rheumatological conditions.

Authors: Wan Yu Png; Yu Heng Kwan; Ka Keat Lim; Eng Hui Chew; Nai Lee Lui; Chuen Seng Tan; Truls Østbye; Julian Thumboo; Warren Fong
Journal: Eur J Hosp Pharm Date: 2018-05-02

9. A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation.

Authors: Asako Chiba; Miho Mizuno; Chiharu Tomi; Ryohsuke Tajima; Iraide Alloza; Alessandra di Penta; Takashi Yamamura; Koen Vandenbroeck; Sachiko Miyake
Journal: Arthritis Res Ther Date: 2012-01-17 Impact factor: 5.156

10. Abatacept versus other biologics in methotrexate inadequate responders with rheumatoid arthritis: you like tomato and I like tomahto... let's call the whole thing off.

Authors: Yusuf Yazici
Journal: Arthritis Res Ther Date: 2012-02-21 Impact factor: 5.156